
EXAMINATION: 



Study: XR Knees Bilateral 



Procedure(s): XRKNEER - XR Knee Right 



XRKNEEL - XR Knee Left 



CLINICAL DETAILS: 



Pain and temperature for 1 day.  Decreased weightbearing. 



COMPARISON: 



None available at time of report 



FINDINGS: 



Right knee: 



No knee joint effusion.  No cortical destruction or periosteal reaction.  No is fracture seen. 



No established changes of osteomyelitis or septic arthritis. 



Left knee: 



No knee joint effusion.  No cortical destruction or periosteal reaction.  No is fracture seen. 



No established changes of osteomyelitis or septic arthritis. 



As x-ray can be insensitive for early OM, consider other imaging modalities or repeat imaging if high clinical suspicion persists. 



REPORTED BY:  XX Registrar, XX/12/2018 09:43 AM 



This report was created by a Radiology Registrar and will be verified by a Radiology Consultant within 24 hours. 



 

-- Addended Report -- 



This report has been checked and verified correct by a Consultant. 



This addendum was created by  XX Consultant, XX/12/2018 06:47 PM 



ORIGINAL REPORT 



EXAMINATION: 



Study: XR Knees Bilateral 



Procedure(s): XRKNEER - XR Knee Right 



XRKNEEL - XR Knee Left 



CLINICAL DETAILS: 



Pain and temperature for 1 day.  Decreased weightbearing. 



COMPARISON: 



None available at time of report 



FINDINGS: 



Right knee: 



No knee joint effusion.  No cortical destruction or periosteal reaction.  No is fracture seen. 



No established changes of osteomyelitis or septic arthritis. 



Left knee: 



No knee joint effusion.  No cortical destruction or periosteal reaction.  No is fracture seen. 



No established changes of osteomyelitis or septic arthritis. 



As x-ray can be insensitive for early OM, consider other imaging modalities or repeat imaging if high clinical suspicion persists. 



REPORTED BY:  XX, Registrar, XX/12/2018 09:43 AM 



This report was created by a Radiology Registrar and will be verified by a Radiology Consultant within 24 hours. 



 
